Top 10 selling drugs for 2024

MSD's Keytruda is forecast to hold its position as the world's top-selling drug in 2024, adding around US$2.6 billion in new sales.

The widely used PD-1 inhibitor skyrocketed to the top spot last year and numbers crunched by Evaluate Pharma, in its latest report 2024 Preview, show it could rake in US$27 billion this year.

However, the analytics company notes that "Keytruda's claim on the top spot is not beyond debate". The forecast names a different winner depending on whether the analysis is by brand name or franchise-based.